X0306 4 2017-10-13 1 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 1 0 0 President, CEO, Director Common Stock 2017-10-13 4 M 0 95000 A 237299 D Common Stock 2017-10-13 4 A 0 150000 0.00 A 387299 D Common Stock 2017-10-13 4 D 0 387299 11.18 D 0 D Non-Qualified Stock Option (right to buy) 5.13 2017-10-13 4 D 0 142610 6.05 D 2021-05-12 Common Stock 142610 0 D Non-Qualified Stock Option (right to buy) 6.22 2017-10-13 4 D 0 200000 4.96 D 2022-03-15 Common Stock 200000 0 D Non-Qualified Stock Option (right to buy) 4.53 2017-10-13 4 D 0 200000 6.65 D 2023-04-04 Common Stock 200000 0 D Non-Qualified Stock Option (right to buy) 4.52 2017-10-13 4 D 0 200000 6.66 D 2024-03-14 Common Stock 200000 0 D Incentive Stock Option (right to buy) 8.83 2017-10-13 4 D 0 42725 2.35 D 2025-03-16 Common Stock 42725 0 D Restricted Stock Unit 2017-10-13 4 M 0 10000 D Common Stock 10000 0 D Non-Qualified Stock Option (right to buy) 8.83 2017-10-13 4 D 0 97275 2.35 D 2025-03-16 Common Stock 97275 0 D Restricted Stock Unit 2017-10-13 4 M 0 50000 D Common Stock 50000 0 D Incentive Stock Option (right to buy) 9.12 2017-10-13 4 D 0 11243 2.06 D 2026-03-15 Common Stock 11243 0 D Non-Qualified Stock Option (right to buy) 9.12 2017-10-13 4 D 0 128757 2.06 D 2026-03-15 Common Stock 128757 0 D Restricted Stock Unit 2017-10-13 4 M 0 15000 D Common Stock 15000 0 D Incentive Stock Option (right to buy) 9.65 2017-10-13 4 D 0 10843 1.53 D 2027-03-08 Common Stock 10843 0 D Non-Qualified Stock Option (right to buy) 9.65 2017-10-13 4 D 0 129157 1.53 D 2027-03-08 Common Stock 129157 0 D Restricted Stock Unit 2017-10-13 4 M 0 20000 D Common Stock 20000 0 D Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement. Includes 216 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on October 6, 2017 and 746 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on August 31, 2017. Shares of SCLN common stock received in settlement of performance rights not constituting derivative securities. Granted under Issuer's 2005 Equity Incentive Plan. Under its terms the option became exercisable in installments with 25% vesting on April 5, 2012 and 2.0833% vesting each month thereafter until it became vested in full on April 5, 2015. The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price. Under its terms the option became exercisable in installments with 25% vesting on March 15, 2013 and 2.0833% vesting each month thereafter until it became vested in full on March 15, 2016. Under its terms the option became exercisable in installments with 25% vesting on April 4, 2014 and 2.0833% vesting each month thereafter until it became vested in full on April 4, 2017. Under its terms the option became exercisable in installments with 25% vesting on March 14, 2015 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger. Under its terms the option became exercisable in installments with 25% vesting on March 16, 2016 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger. Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock. Granted under Issuer's 2015 Equity Incentive Plan. Under its terms the option became exercisable in installments with 25% vesting on March 15, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger. Under its terms the option became exercisable in installments with 25% to vest on March 8, 2018 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger. /s/ Friedhelm Blobel, Ph.D. 2017-10-16